Johnson & Johnson (JNJ)
149.56
+0.44
(+0.30%)
USD |
NYSE |
Apr 23, 16:00
149.56
0.00 (0.00%)
After-Hours: 20:00
Johnson & Johnson Revenue (Quarterly): 21.38B for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.38B |
| December 31, 2023 | 21.40B |
| September 30, 2023 | 21.35B |
| June 30, 2023 | 25.53B |
| March 31, 2023 | 24.75B |
| December 31, 2022 | 19.94B |
| September 30, 2022 | 20.00B |
| June 30, 2022 | 24.02B |
| March 31, 2022 | 23.43B |
| December 31, 2021 | 9.769B |
| September 30, 2021 | 23.34B |
| June 30, 2021 | 23.31B |
| March 31, 2021 | 22.32B |
| December 31, 2020 | 22.48B |
| September 30, 2020 | 21.08B |
| June 30, 2020 | 18.34B |
| March 31, 2020 | 20.69B |
| December 31, 2019 | 20.75B |
| September 30, 2019 | 20.73B |
| June 30, 2019 | 20.56B |
| March 31, 2019 | 20.02B |
| December 31, 2018 | 20.39B |
| September 30, 2018 | 20.35B |
| June 30, 2018 | 20.83B |
| March 31, 2018 | 20.01B |
| Date | Value |
|---|---|
| December 31, 2017 | 20.20B |
| September 30, 2017 | 19.65B |
| June 30, 2017 | 18.84B |
| March 31, 2017 | 17.77B |
| December 31, 2016 | 18.11B |
| September 30, 2016 | 17.82B |
| June 30, 2016 | 18.48B |
| March 31, 2016 | 17.48B |
| December 31, 2015 | 17.81B |
| September 30, 2015 | 17.10B |
| June 30, 2015 | 17.79B |
| March 31, 2015 | 17.37B |
| December 31, 2014 | 18.25B |
| September 30, 2014 | 18.47B |
| June 30, 2014 | 19.50B |
| March 31, 2014 | 18.12B |
| December 31, 2013 | 18.36B |
| September 30, 2013 | 17.58B |
| June 30, 2013 | 17.88B |
| March 31, 2013 | 17.50B |
| December 31, 2012 | 17.56B |
| September 30, 2012 | 17.05B |
| June 30, 2012 | 16.48B |
| March 31, 2012 | 16.14B |
| December 31, 2011 | 16.26B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.769B
Minimum
Dec 2021
25.53B
Maximum
Jun 2023
21.26B
Average
21.37B
Median
Revenue (Quarterly) Benchmarks
| Amgen Inc | 8.196B |
| Gilead Sciences Inc | 7.114B |
| Eli Lilly and Co | 9.353B |
| Merck & Co Inc | 14.63B |
| Shockwave Medical Inc | 202.98M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.354B |
| Total Expenses (Quarterly) | 15.31B |
| EPS Diluted (Quarterly) | 2.20 |
| Enterprise Value | 366.81B |
| Gross Profit Margin (Quarterly) | 69.55% |
| Profit Margin (Quarterly) | 25.04% |
| Earnings Yield | 9.59% |
| Operating Earnings Yield | 6.16% |
| Normalized Earnings Yield | 5.472 |